You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the European Union Drugs Agency (EUDA).

Table TDI-18. Frequency of use of primary drug among new outpatient clients in 2004 – Part (ii) Percentage distribution among clients with cannabis as primary drug

Country

Not used in the past month/ Occasional

Once a week or less

2 to 6 times per week

Daily

Base
(known status)

Status unknown

Czech Republic

15.5

32.3

35.0

17.2

303

18

Denmark

0.0

7.1

18.8

74.2

496

52

Germany

39.4

8.3

21.9

30.5

7053

2422

Greece

33.0

15.9

24.4

26.7

176

17

Italy

38.4

30.6

11.1

19.9

2414

3469

Cyprus

9.3

11.1

11.1

68.5

54

1

Latvia

6.7

11.7

78.3

3.3

60

11

Hungary

48.9

27.8

0.0

23.3

2675

0

Malta

0.0

0.0

0.0

100.0

1

0

Netherlands

7.9

2.3

8.6

81.2

1655

171

Slovenia

10.9

25.7

50.5

12.9

101

0

Slovakia

6.7

20.0

40.0

33.3

60

1

Finland

18.1

33.6

34.9

13.4

238

13

Sweden

18.6

23.3

29.4

28.8

344

10

Bulgaria

13.9

41.7

25.0

19.4

36

3

 

 

 

 

 

 

 

Total

34.4

15.9

16.1

33.7

15666

6188

Notes:

Only countries where there are clients with cannabis reported as primary drug are shown.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2005 Reitox national reports - Table TDI outpatient treatment centres

Data filter | tditab18b-en.xml